The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17

ConclusionsOur work demonstrates the significant cost of medication to modulate tissue glucose levels in type 2 diabetes and the dominance of some non‐generic preparations in terms of number of prescriptions and overall spend. There are some older sulphonylureas in use, which should not generally be prescribed. Regular audit of patient treatment at a general practice level will ensure appropriate targeted use of licensed medications and of their cost effectiveness.

Source: International Journal of Clinical Practice - February 1, 2018 Category: Internal Medicine Authors: Adrian H. Heald, Mark Livingston, Zuzanna Bien, Gabriela Y.C. Moreno, Ian Laing, Mike Stedman Tags: SHORT REPORT Source Type: research